Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thyroid Neoplasms × radium Ra 223 dichloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 30 Neoplasm Metastasis 5 Breast Neoplasms 4 Prostate Carcinoma Metastatic to the Bone 2 Multiple Myeloma 2 Hormone Refractory Prostate Cancer 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Prostate Cancer Metastatic to Bone 1 Prostate Adenocarcinoma 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-resistant Prostate Cancer 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Castrate-Resistant Prostate Cancer 1 Bone Metastatic Castration-resistant Prostate Cancer 1 Bone Diseases 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Iodine-131 14 lenvatinib 11 Magnetic Resonance Spectroscopy 10 trametinib 9 Thyrotropin Alfa 9 Sorafenib 9 vandetanib 8 pembrolizumab 8 Paclitaxel 8 dabrafenib 7 Thyroxine 7 selpercatinib 6 Surgical Procedures, Operative 6 Sunitinib 6 Everolimus 6 pazopanib 5 cabozantinib 5 Vemurafenib 5 Saline Solution 5 Cyclophosphamide 5 anlotinib 4 Triiodothyronine 4 Thyroidectomy 4 Radiofrequency Ablation 4 Nivolumab 4 Fluorodeoxyglucose F18 4 Docetaxel 4 Dexmedetomidine 4 fosbretabulin 3 durvalumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02390934 2019-06-11

RAD-THYR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡